✦ LIBER ✦

The Effect of Thioguanine on a Combination of Daunorubicine, Cytarabine and Prednisone in the Treatment of Acute Leukaemia in Adults

✍ Scribed by Ikkala, E. ;Lahtinen, R. ;Niskanen, E. ;Ruutu, T. ;Vuopio, P. ;Hänninen, Auli ;Palva, I. ;Timonen, T. ;Lehtinen, Marja ;Levanto, A. ;Rajamäki, A. ;Vilpo, J. ;Selroos, O. ;Ahrenberg, Pia ;Rosengård, S. ;Waris, E. ;Wasastjerna, C. ;Wasastjerna, C. ;Sarna, S. ;,

Book ID: 114789344
Publisher: Wiley (Blackwell Publishing)
Year: 2009
Weight: 310 KB
Volume: 23
Category: Article
ISSN: 0036-553X
DOI: 10.1111/j.1600-0609.1979.tb02683.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised clinical trial comparing id

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia

✍ Mandelli, Franco; Petti, Maria C.; Ardia, Alfredo; Di Pietro, Nicola; Di Raimond 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 793 KB

Treatment of Acute Myeloid Leukaemia wit

Treatment of Acute Myeloid Leukaemia with Daunorubicin, Cytosine Arabinoside, Mercaptopurine, L-Asparaginase, Prednisone and Thioguanine: Results of Treatment with Five Multiple-Drug Schedules : Report of the Medical Research Council's Working Party on Leukaemia in Adults

📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 988 KB

Effect of cloretazine (VNP40101M) on acu

Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin

✍ Karen L. Morris; Julie A. Adams; John A. Liu Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 612 KB

We have investigated the effect of cloretazine (VNP40101M or Laromustine), a novel sulfonylhydrazine alkylating agent with significant antileukaemic activity, alone, or combined with cytarabine or daunorubicin, on the proliferation, viability and apoptosis of cell lines and acute myeloid leukaemia b

Population pharmacokinetics of cytarabin

Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia

✍ Mikkel Krogh-Madsen; Brendan Bender; Morten Krogh Jensen; Ove Juul Nielsen; Lena 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 346 KB

Oral treatment of acute myeloid leukaemi

Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle

✍ T. Ruutu; E. Koivunen; T. Nousiainen; T.-T. Pelliniemi; A. Almqvist; P. Anttila; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

A comparative trial of daunorubicin, cyt

A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemia

✍ Wiernik, Peter H. ;Glidewell, Oliver J. ;Hoagland, H. Clark ;Brunner, Kurt W. ;S 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 767 KB

In this study 523 previously untreated patients with acute myelocytic leukemia were randomly allocated to induction therapy with daunorubicin 60 mg/M2 daily X 3, cytosine arabinoside and thioguanine 100 mg/M2 each every 12 hours until marrow hypoplasia was achieved, or a 5-day course of the three dr